JNJ | Johnson & Johnson | $0.6t | $276.98 | -1.8% | 4.4M |
ABBV | ABBVIE INC. | $0.5t | $291.04 | -1.0% | 2.4M |
MRK | Merck & Co., Inc. | $356.9b | $142.44 | -1.4% | 5.4M |
AZN | AstraZeneca PLC | $285.2b | $182.52 | -1.0% | 1.9M |
AMGN | Amgen Inc | $249.4b | $455.45 | -1.0% | 1.2M |
BMY | Bristol-Myers Squibb Co. | $126.1b | $61.06 | -3.3% | 12.0M |
REGN | Regeneron Pharmaceuticals Inc | $100.7b | $955.00 | +0.6% | 503.8K |
MRNA | Moderna, Inc. Common Stock | $91.2b | $209.50 | -3.9% | 7.1M |
RPRX | Royalty Pharma plc Class A Ordinary Shares | $29.6b | $68.14 | +0.2% | 2.1M |
IBRX | ImmunityBio, Inc. Common Stock | $8.8b | $6.28 | +4.7% | 10.3M |
ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
CGON | CG Oncology, Inc. Common stock | $5.7b | $79.47 | -6.9% | 3.0M |
IOVA | Iovance Biotherapeutics, Inc. Common Stock | $4.0b | $7.54 | -0.1% | 8.0M |
RCUS | Arcus Biosciences, Inc. | $2.4b | $15.97 | -2.8% | 1.7M |
XNCR | Xencor, Inc. | $2.3b | $34.49 | -2.5% | 764.6K |
REPL | Replimune Group, Inc. | $2.0b | $19.80 | -8.0% | 2.2M |
PGEN | Precigen, Inc. Common Stock | $1.9b | $4.36 | -0.5% | 3.4M |
SLS | SELLAS Life Sciences Group, Inc. Common Stock | $1.8b | $17.09 | +134.1% | 113.9M |
OMER | Omeros Corporation | $1.3b | $14.02 | -16.5% | 5.1M |
NKTR | Nektar Therapeutics | $1.3b | $36.67 | -1.4% | 569.1K |
SNDX | Syndax Pharmaceuticals, Inc. | $1.3b | $9.41 | +0.7% | 2.0M |
INBX | Inhibrx Biosciences, Inc. Common Stock | $1.2b | $74.14 | -4.7% | 231.5K |
JANX | Janux Therapeutics, Inc. Common Stock | $1.1b | $10.79 | -1.8% | 601.7K |
IMTX | Immatics N.V. Ordinary Shares | $1.1b | $6.29 | +2.0% | 1.4M |
CGEM | Cullinan Therapeutics, Inc. Common Stock | $1.0b | $9.28 | -2.4% | 1.5M |
CRVS | Corvus Pharmaceuticals, Inc. | $0.8b | $10.33 | -4.1% | 793.3K |
CADL | Candel Therapeutics, Inc. Common Stock | $0.7b | $5.39 | -6.9% | 1.6M |
AURA | Aura Biosciences, Inc. Common Stock | $0.6b | $7.14 | -1.0% | 541.2K |
BCAX | Bicara Therapeutics Inc. Common Stock | $0.6b | $9.60 | -1.5% | 706.8K |
CBIO | Crescent Biopharma, Inc. Common Stock | $485.1m | $13.32 | -3.3% | 180.5K |
CTMX | CytomX Therapeutics, Inc. | $475.0m | $2.03 | -1.8% | 1.8M |
INDP | Indaptus Therapeutics, Inc. Common Stock | $431.7m | $3.33 | -2.9% | 275.7K |
AGEN | Agenus Inc. | $301.2m | $6.19 | -1.0% | 786.3K |
GLSI | Greenwich LifeSciences, Inc. | $233.7m | $18.83 | +35.0% | 1.1M |
CGEN | Compugen Ltd | $190.4m | $2.02 | -0.5% | 195.2K |
ALXO | ALX Oncology Holdings Inc. Common Stock | $178.4m | $1.00 | +0.5% | 365.1K |
VRXA | Veraxa Biotech AG Ordinary Shares | $157.0m | $1.06 | +0.5% | 110.5K |
CUE | Cue Biopharma, Inc. | $151.5m | $3.11 | -79.1% | 3.8M |
MGNX | MacroGenics, Inc. | $148.4m | $2.05 | -5.5% | 506.7K |
CMPX | Compass Therapeutics, Inc. Common Stock | $135.6m | $0.61 | -8.9% | 2.7M |
CHRS | Coherus Oncology, Inc. Common Stock | $124.5m | $0.47 | -4.4% | 3.1M |
ANIX | Anixa Biosciences, Inc. | $106.2m | $2.66 | +4.3% | 222.5K |
HURA | TuHURA Biosciences, Inc. Common Stock | $105.5m | $1.48 | +4.5% | 471.8K |
PDSB | PDS Biotechnology Corporation Common Stock | $104.4m | $0.91 | -1.5% | 3.0M |
GNLX | Genelux Corporation Common Stock | $86.9m | $2.03 | +3.6% | 248.2K |
MAIA | MAIA Biotechnology, Inc. | $66.7m | $1.26 | +20.8% | 1.7M |
XBIT | XBiotech Inc | $60.7m | $1.77 | -3.2% | 61.5K |
XLO | Xilio Therapeutics, Inc. Common Stock | $57.1m | $7.62 | +1.4% | 6.1K |
HOWL | Werewolf Therapeutics, Inc. Common Stock | $52.0m | $0.98 | +2.4% | 998.5K |
ONCY | Oncolytics Biotech, Inc. Common Shares | $51.1m | $0.39 | +13.8% | 1.6M |